SpyBiotech
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $38M
Investors
- 5
About SpyBiotech
SpyBiotech Limited, based in the UK, specializes in biotechnology, focusing on developing innovative vaccines utilizing its proprietary protein superglue technology.SpyBiotech Limited, founded in 2017 in Oxford, UK, concentrates on innovative vaccine development. The CEO is Mark Leuchtenberger, and the company is founded by Simon Draper.SpyBiotech is focused on developing innovative vaccines using its proprietary protein superglue technology, SpyTag/SpyCatcher. This technology facilitates the creation of safe vaccines aimed at preventing infectious diseases and treating cancer. The company's primary product pipeline includes a vaccine targeting cytomegalovirus (CMV).SpyBiotech’s revenue model is based on collaborations with healthcare organizations and pharmaceutical companies engaged in vaccine development.60.80 million to advance clinical development of its novel vaccine technology platform. The company aims to expand its market presence in Europe and North America as it develops new products.
Who invested in SpyBiotech
5 investors across 2 rounds
See all investors in SpyBiotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SpyBiotech
Who invested in SpyBiotech?
SpyBiotech has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SpyBiotech raised?
SpyBiotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SpyBiotech last raise money?
SpyBiotech's most recent round on record is a Series A, in Feb 2021.
What does SpyBiotech do?
SpyBiotech Limited, based in the UK, specializes in biotechnology, focusing on developing innovative vaccines utilizing its proprietary protein superglue technology.
Where is SpyBiotech headquartered?
SpyBiotech is headquartered in Oxford, UK.
Which VCs invest in companies like SpyBiotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at SpyBiotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SpyBiotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.